High-dose interleukin-2 (hd-IL2) in treatment-naïve metastatic renal cell carcinoma (mrcc) - a 10 year single-site experience and outcome of prospective pathology-based patient selection
Shien Chow, Manon Evans, Victoria Galvis, Rebecca Leach, Elizabeth Keene, Kevin Chan, Andrea Spencer-Shaw, Shanks Jonathan, Alaaeldin Shabalak, Fiona Thistlethwaite, Robert Hawkins
Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P89; DOI: 10.1186/2051-1426-2-S3-P89